Microenvironment-Driven Dynamic Heterogeneity and Phenotypic Plasticity as a Mechanism of Melanoma Therapy Resistance

Por Ahmed, Farzana, Haass, Nikolas K.
Publicado no Front Oncol (2018)

Switching the Sphingolipid Rheostat in the Treatment of Diabetes and Cancer Comorbidity from a Problem to an Advantage

Por Haass, Nikolas K., Nassif, Najah, McGowan, Eileen M.
Publicado no Biomed Res Int (2015)

Modeling Melanoma In Vitro and In Vivo

Por Beaumont, Kimberley A., Mohana-Kumaran, Nethia, Haass, Nikolas K.
Publicado no Healthcare (Basel) (2013)

The Role of Melanoma Cell-Stroma Interaction in Cell Motility, Invasion, and Metastasis

Por Ju, Robert J., Stehbens, Samantha J., Haass, Nikolas K.
Publicado no Front Med (Lausanne) (2018)

Editorial: Recent Developments in Therapies and Diagnostic Tools for Melanoma and Non-melanoma Skin Cancer

Por Fujimura, Taku, Fujisawa, Yasuhiro, Otsuka, Atsushi, Haass, Nikolas K.
Publicado no Front Med (Lausanne) (2020)

Imaging- and Flow Cytometry-based Analysis of Cell Position and the Cell Cycle in 3D Melanoma Spheroids

Por Beaumont, Kimberley A., Anfosso, Andrea, Ahmed, Farzana, Weninger, Wolfgang, Haass, Nikolas K.
Publicado no J Vis Exp (2015)

Mathematical Models for Cell Migration with Real-Time Cell Cycle Dynamics

Por Vittadello, Sean T., McCue, Scott W., Gunasingh, Gency, Haass, Nikolas K., Simpson, Matthew J.
Publicado no Biophys J (2018)

Mathematical models incorporating a multi-stage cell cycle replicate normally-hidden inherent synchronization in cell proliferation

Por Vittadello, Sean T., McCue, Scott W., Gunasingh, Gency, Haass, Nikolas K., Simpson, Matthew J.
Publicado no J R Soc Interface (2019)

Examining Go-or-Grow Using Fluorescent Cell-Cycle Indicators and Cell-Cycle-Inhibiting Drugs

Por Vittadello, Sean T., McCue, Scott W., Gunasingh, Gency, Haass, Nikolas K., Simpson, Matthew J.
Publicado no Biophys J (2020)

Up-Regulated Expression of Zonula Occludens Protein-1 in Human Melanoma Associates with N-Cadherin and Contributes to Invasion and Adhesion

Por Smalley, Keiran S.M., Brafford, Patricia, Haass, Nikolas K., Brandner, Johanna M., Brown, Eric, Herlyn, Meenhard
Publicado em 2005

Expression of Integrin Alpha10 Is Induced in Malignant Melanoma

Por Wenke, Ann-Kathrin, Kjellman, Christian, Lundgren-Akerlund, Evy, Uhlmann, Christian, Haass, Nikolas K., Herlyn, Meenhard, Bosserhoff, Anja K.
Publicado no Cell Oncol (2007)

Evaluation of Cell Cycle Arrest in Estrogen Responsive MCF-7 Breast Cancer Cells: Pitfalls of the MTS Assay

Por McGowan, Eileen M., Alling, Nikki, Jackson, Elise A., Yagoub, Daniel, Haass, Nikolas K., Allen, John D., Martinello-Wilks, Rosetta
Publicado em 2011

Magnolol induces cell death through PI3K/Akt‐mediated epigenetic modifications boosting treatment of BRAF‐ and NRAS‐mutant melanoma

Por Emran, Abdullah Al, Chinna Chowdary, Brinda Reddy, Ahmed, Farzana, Hammerlindl, Heinz, Huefner, Antje, Haass, Nikolas K., Schuehly, Wolfgang, Schaider, Helmut
Publicado no Cancer Med (2019)

Cover Image

Por Emran, Abdullah Al, Chinna Chowdary, Brinda Reddy, Ahmed, Farzana, Hammerlindl, Heinz, Huefner, Antje, Haass, Nikolas K., Schuehly, Wolfgang, Schaider, Helmut
Publicado no Cancer Med (2019)

PLX4032, a Potent Inhibitor of the B-Raf V600E Oncogene, Selectively Inhibits V600E-positive Melanomas

Por Lee, John T., Li, Ling, Brafford, Patricia A., van den Eijnden, Marcia, Halloran, Molly B., Sproesser, Katrin, Haass, Nikolas K., Smalley, Keiran S.M., Tsai, James, Bollag, Gideon, Herlyn, Meenhard
Publicado em 2010

Acetylsalicylic Acid Governs the Effect of Sorafenib in RAS Mutant Cancers

Por Hammerlindl, Heinz, Menon, Dinoop Ravindran, Hammerlindl, Sabrina, Emran, Abdullah Al, Torrano, Joachim, Sproesser, Katrin, Thakkar, Divya, Xiao, Min, Atkinson, Victoria G., Gabrielli, Brian, Haass, Nikolas K., Herlyn, Meenhard, Krepler, Clemens, Schaider, Helmut
Publicado no Clin Cancer Res (2017)

Combined use of subclinical hydroxyurea and CHK1 inhibitor effectively controls melanoma and lung cancer progression, with reduced normal tissue toxicity compared to gemcitabine

Por Oo, Zay Yar, Proctor, Martina, Stevenson, Alexander J., Nazareth, Deborah, Fernando, Madushan, Daignault, Sheena M., Lanagan, Catherine, Walpole, Sebastian, Bonazzi, Vanessa, Škalamera, Dubravka, Snell, Cameron, Haass, Nikolas K., Larsen, Jill E., Gabrielli, Brian
Publicado no Mol Oncol (2019)

Rapid initiation of cell cycle reentry processes protects neurons from amyloid-β toxicity

Por Ippati, Stefania, Deng, Yuanyuan, van der Hoven, Julia, Heu, Celine, van Hummel, Annika, Chua, Sook Wern, Paric, Esmeralda, Chan, Gabriella, Feiten, Astrid, Fath, Thomas, Ke, Yazi D., Haass, Nikolas K., Ittner, Lars M.
Publicado no Proc Natl Acad Sci U S A (2021)

microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB

Por Giles, Keith M., Brown, Rikki A.M, Ganda, Clarissa, Podgorny, Melissa J., Candy, Patrick A., Wintle, Larissa C., Richardson, Kirsty L., Kalinowski, Felicity C., Stuart, Lisa M., Epis, Michael R., Haass, Nikolas K., Herlyn, Meenhard, Leedman, Peter J.
Publicado no Oncotarget (2016)

Genome-wide gain-of-function screen for genes that induce epithelial-to-mesenchymal transition in breast cancer

Por Škalamera, Dubravka, Dahmer-Heath, Mareike, Stevenson, Alexander J., Pinto, Cletus, Shah, Esha T., Daignault, Sheena M., Said, Nur Akmarina B.M., Davis, Melissa, Haass, Nikolas K., Williams, Elizabeth D., Hollier, Brett G., Thompson, Erik W., Gabrielli, Brian, Gonda, Thomas J.
Publicado no Oncotarget (2016)